Zion Research has published a new report titled “Cancer
Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone
Therapy and Others) for Breast Cancer, Blood Cancer, Gastrointestinal Cancer,
Prostate Cancer, Skin Cancer, Lung Cancer and Other Cancer: Global Industry
Perspective, Comprehensive Analysis and Forecast, 2015 - 2021”. According to
the report, global demand for cancer drugs market was
valued at approximately USD 112.90 billion in 2015 and is expected to generate
revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of
around 7.4% between 2016 and 2021.
Request Free Sample copy of Research
Report @ https://www.zionmarketresearch.com/sample/cancer-drugs-market
Cancer is defined as a disease which occurs as a result of
changes in a group of normal cells within the body which leads to uncontrolled
growth resulting in the formation of lump called a tumor; (except for cancer of
the blood). If left untreated, tumors can grow and spread into the surrounding
normal tissue, or to other parts of the body via lymphatic systems and the
bloodstream, and can in turn severely impact the functioning of the digestive,
nervous and circulatory systems.
Global cancer drugs market is primarily driven by growing
incidences of target disease such as lung cancer, breast cancer, cervical
cancer, etc. across the globe. Other major driving factors are increasing
research and development on biological and targeted drug therapies for the
treatment of cancer coupled along with the expiration of patents. However, the
high price of drug development and stringent regulatory policies coupled along
with the possibility of failure are the major restraints that may limit the
growth of the market. Nonetheless increasing focus on personalized medicine
coupled along with huge investment in anti-cancer drugs research across the
globe is likely to disclose the new avenues for cancer drugs market in the near
future.
The cancer drugs market is segmented on the basis of the
different therapeutic segment including immunotherapy, targeted therapy,
chemotherapy, hormone therapy and others. Immunotherapy segment is expected to
grow at fastest rate in the global market over the forecast period.
Breast cancer, blood cancer, gastrointestinal cancer,
prostate cancer, skin cancer, lung cancer and others are the key cancer types
of the global cancer drugs market. The blood cancer segment dominated the
market in terms of revenue.
North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global cancer drugs market. North America is anticipated to remain the leading region over the forecast period in 2015. Demand for cancer drugs was highest in North America especially in the U.S. Hence, Asia Pacific is expected to be the moderate growing region in cancer drugs market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show moderate growth for this market in the years to come.
North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global cancer drugs market. North America is anticipated to remain the leading region over the forecast period in 2015. Demand for cancer drugs was highest in North America especially in the U.S. Hence, Asia Pacific is expected to be the moderate growing region in cancer drugs market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show moderate growth for this market in the years to come.
Some of the key players in cancer drugs market include
Bayer, GlaxoSmithKline, Novartis, Sanofi and Pfizer, Amgen, Merck,
Bristol-Myers Squibb, Celgene Corporation, Ariad Pharmaceuticals, Eli Lilly,
Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, Johnson and Johnson and Teva
Pharmaceuticals among others.
Browse detail report with in-depth
TOC @ https://www.zionmarketresearch.com/report/cancer-drugs-market
This report segments the global cancer drugs market as
follows:
Global Cancer Drugs Market: Therapy Segment Analysis
Global Cancer Drugs Market: Therapy Segment Analysis
·
Immunotherapy
·
Targeted Therapy
·
Chemotherapy
·
Hormone Therapy
·
Others
Global Cancer Drugs Market: Application Segment Analysis.
·
Breast Cancer
·
Blood Cancer
·
Gastrointestinal Cancer
·
Prostate Cancer
·
Skin Cancer
·
Lung Cancer
·
Others
Global Cancer Drugs Market: Regional Segment Analysis
·
North America
o
U.S.
·
Europe
o
UK
o
France
o
Germany
·
Asia Pacific
o
China
o
Japan
o
India
·
Latin America
o
Brazil
·
The Middle East and
Africa
About Us:
Zion Market Research is an obligated company. We
create futuristic, cutting edge, informative reports ranging from industry
reports, company reports to country reports. We provide our clients not only
with market statistics unveiled by avowed private publishers and public organizations
but also with vogue and newest industry reports along with pre-eminent and
niche company profiles. Our database of market research reports comprises a
wide variety of reports from cardinal industries. Our database is been updated
constantly in order to fulfill our clients with prompt and direct online access
to our database. Keeping in mind the client’s needs, we have included expert
insights on global industries, products, and market trends in this database.
Last but not the least, we make it our duty to ensure the success of clients
connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
4283, Express Lane,
Suite 634-143,
Sarasota, Florida 34249, United
States
Tel: +49-322 210 92714
USA/Canada Toll Free
No.1-855-465-4651
No comments:
Post a Comment